Arkolith/Insider Trading/CCXI/Form 4

Schall Thomas J.

President and CEO, DirectorChemoCentryx, Inc. (CCXI) · full profile →Form 4 · filed Aug 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.5M
Net Open-Market Flow
-$6.5M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)130K$14.28$1.9M2.5M
Aug 4, 2022Sell(S)130K$50.24$6.5M2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)130K——35K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-044896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ChemoCentryx, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp